1
|
Masias Bruns M, Ramirez-Mahaluf JP, Valli I, Ortuño M, Ilzarbe D, de la Serna E, Navarro OP, Crossley NA, González Ballester MÁ, Baeza I, Piella G, Castro-Fornieles J, Sugranyes G. Altered Temporal Dynamics of Resting-State Functional Magnetic Resonance Imaging in Adolescent-Onset First-Episode Psychosis. Schizophr Bull 2024; 50:418-426. [PMID: 37607335 PMCID: PMC10919773 DOI: 10.1093/schbul/sbad107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 08/24/2023]
Abstract
BACKGROUND Dynamic functional connectivity (dFC) alterations have been reported in patients with adult-onset and chronic psychosis. We sought to examine whether such abnormalities were also observed in patients with first episode, adolescent-onset psychosis (AOP), in order to rule out potential effects of chronicity and protracted antipsychotic treatment exposure. AOP has been suggested to have less diagnostic specificity compared to psychosis with onset in adulthood and occurs during a period of neurodevelopmental changes in brain functional connections. STUDY DESIGN Seventy-nine patients with first episode, AOP (36 patients with schizophrenia-spectrum disorder, SSD; and 43 with affective psychotic disorder, AF) and 54 healthy controls (HC), aged 10 to 17 years were included. Participants underwent clinical and cognitive assessments and resting-state functional magnetic resonance imaging. Graph-based measures were used to analyze temporal trajectories of dFC, which were compared between patients with SSD, AF, and HC. Within patients, we also tested associations between dFC parameters and clinical variables. STUDY RESULTS Patients with SSD temporally visited the different connectivity states in a less efficient way (reduced global efficiency), visiting fewer nodes (larger temporal modularity, and increased immobility), with a reduction in the metabolic expenditure (cost and leap size), relative to AF and HC (effect sizes: Cohen's D, ranging 0.54 to.91). In youth with AF, these parameters did not differ compared to HC. Connectivity measures were not associated with clinical severity, intelligence, cannabis use, or dose of antipsychotic medication. CONCLUSIONS dFC measures hold potential towards the development of brain-based biomarkers characterizing adolescent-onset SSD.
Collapse
Affiliation(s)
- Mireia Masias Bruns
- BCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
| | - Juan Pablo Ramirez-Mahaluf
- BCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
- Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Isabel Valli
- Clinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - María Ortuño
- Clinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Daniel Ilzarbe
- Clinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Department of Child and Adolescent Psychiatry, 2017SGR881, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain
- Group G04, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain
- Department of Medicine, Universitat de Barcelona, Barcelona, Spain
| | - Elena de la Serna
- Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
- Department of Child and Adolescent Psychiatry, 2017SGR881, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain
- Group G04, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain
| | - Olga Puig Navarro
- Department of Child and Adolescent Psychiatry, 2017SGR881, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain
- Group G04, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain
| | - Nicolas A Crossley
- Department of Psychiatry, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Miguel Ángel González Ballester
- BCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
- Clinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain
- ICREA, Barcelona, Spain
| | - Inmaculada Baeza
- Clinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Department of Child and Adolescent Psychiatry, 2017SGR881, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain
- Group G04, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain
- Department of Medicine, Universitat de Barcelona, Barcelona, Spain
| | - Gemma Piella
- BCN-MedTech, Department of Information and Communication Technologies, Universitat Pompeu Fabra, Barcelona, Spain
| | - Josefina Castro-Fornieles
- Clinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Department of Child and Adolescent Psychiatry, 2017SGR881, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain
- Group G04, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain
- Department of Medicine, Universitat de Barcelona, Barcelona, Spain
| | - Gisela Sugranyes
- Clinical and Experimental Neuroscience, Fundació de Recerca Clínic Barcelona, Institut d’Investigacions Biomèdiques Agustí Pi i Sunyer (IDIBAPS), Barcelona, Spain
- Department of Child and Adolescent Psychiatry, 2017SGR881, Institute of Neuroscience, Hospital Clínic de Barcelona, Barcelona, Spain
- Group G04, Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Spain
- Department of Medicine, Universitat de Barcelona, Barcelona, Spain
| |
Collapse
|